WallStreetZenWallStreetZen

NASDAQ: VIR
Vir Biotechnology Inc Earnings & Revenue

VIR past revenue growth

How has VIR's revenue growth performed historically?
Company
-94.67%
Industry
169.3%
Market
17.86%
VIR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VIR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VIR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VIR earnings and revenue history

Current Revenue
$86.2M
Current Earnings
-$615.1M
Current Profit Margin
-713.7%

VIR Return on Equity

Current Company
-34.9%
Current Industry
-63.4%
Current Market
188%
VIR's Return on Equity (-34.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VIR announces earnings.

VIR Return on Assets

Current Company
-27.7%
Current Industry
3.2%
VIR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VIR Return on Capital Employed

Current Company
-36.02%
Current Industry
19.9%
VIR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VIR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VIR$86.18M-$601.03M-$615.06M+51.87%N/A
XNCR$168.34M-$108.78M-$126.09M+32.90%N/A
PRTA$91.37M-$152.07M-$147.03M+148.98%N/A
AKRO$0.00-$148.40M-$151.76MN/AN/A
DAWN$0.00-$188.53M-$188.92MN/AN/A

VIR earnings dates

Next earnings date
May 2, 2024

Vir Biotechnology Earnings & Revenue FAQ

What were VIR's earnings last quarter?

On Invalid Date, Vir Biotechnology (NASDAQ: VIR) reported Q4 2023 earnings per share (EPS) of -$0.86, up 11.69% year over year. Total Vir Biotechnology earnings for the quarter were -$115.97 million. In the same quarter last year, Vir Biotechnology's earnings per share (EPS) was -$0.77.

If you're new to stock investing, here's how to buy Vir Biotechnology stock.

What was VIR's earnings growth in the past year?

As of Q1 2024, Vir Biotechnology's earnings has grown year over year. Vir Biotechnology's earnings in the past year totalled -$615.06 million.

What is VIR's earnings date?

Vir Biotechnology's earnings date is Invalid Date. Add VIR to your watchlist to be reminded of VIR's next earnings announcement.

What was VIR's revenue last quarter?

On Invalid Date, Vir Biotechnology (NASDAQ: VIR) reported Q4 2023 revenue of $16.79 million up 66.03% year over year. In the same quarter last year, Vir Biotechnology's revenue was $49.41 million.

What was VIR's revenue growth in the past year?

As of Q1 2024, Vir Biotechnology's revenue has grown -94.67% year over year. This is 263.96 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Vir Biotechnology's revenue in the past year totalled $86.18 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.